Huaboron Neutron Technology Secures Over RMB 100 Million in Angel Financing for BNCT System
Huaboron Neutron Technology (Hangzhou) Co., Ltd (HBNCT) has reportedly secured more than RMB 100 million...
ICE Bioscience Secures Series B+ Financing to Boost Integration Capabilities
Beijing-based Contract Research Organization (CRO) ICE Bioscience has reportedly raised close to RMB 100 million...
Sumitomo Pharma and Otsuka’s Ulotaront Fails to Meet Primary Endpoint in Schizophrenia Trials
Japan-based Sumitomo Pharma Co., Ltd (TYO: 4506) and Otsuka Pharmaceutical Co., Ltd (FRA: OS1) have...
Siemens Healthineers Reports 3.6% YOY Revenue Growth in Q3 2023 Financials
Germany-based life sciences giant Siemens Healthineers AG (ETR: SHL) has released its financial results for...
Biogen Inc. to Acquire Reata Pharmaceuticals in $7.3 Billion Deal
US-based Biogen Inc., (NASDAQ: BIIB) has announced that it has reached an agreement to fully...
Pfizer Inc. Reports Q2 2023 Revenues, Signals Shift Beyond COVID-19 Products
US pharmaceutical giant Pfizer Inc., (NYSE: PFE) has released its financial results for the second...
EQRx Inc. to be Acquired by Revolution Medicines in All-Stock Transaction
US-based EQRx Inc. (NASDAQ: EQRX) has revealed that a definitive agreement has been signed for...
GSK Partners with Zuellig Pharma for Vaccine Distribution and Cold-Chain Management in Asia-Pacific
GlaxoSmithKline (GSK; NYSE: GSK), a leading global vaccine manufacturer, has signed an agreement with Philippines-based...
Luye Pharma’s Parkinson’s Disease Treatment LY03003 Receives NMPA Review Acceptance
Luye Pharma Group (HKG: 2186) has announced that the National Medical Products Administration (NMPA) has...
Mabwell Bioscience Secures Licensing Deals for Denosumab Biosimilars in Egypt and Pakistan
China-based Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) has announced separate licensing and commercialization agreements...
GeneMind Biosciences Secures RMB 400 Million in Series C Financing to Expand Gene Testing
Shenzhen-based DNA sequencer specialist, GeneMind Biosciences Co., Ltd, has reportedly raised RMB 400 million in...
Guangzhou Wondfo Biotech Partners with Indonesia’s Kimia Farma in IVD Field
China-based Guangzhou Wondfo Biotech Co., Ltd (SHE: 300482) has entered into a partnership with Indonesia’s...
InxMed Partners with GeneQuantum Healthcare to Develop Innovative ADCs
China-based firm InxMed (Nanjing) Co., Ltd has announced a strategic partnership with compatriot firm GeneQuantum...
Sansure Biotech Partners with Indonesian Firm for Localized Molecular Diagnostic Production
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has announced a strategic partnership with...
Sinopharm Partners with Harbin Institute of Technology to Boost Biomedical Industry Innovation
China National Pharmaceutical Group Corporation (Sinopharm, HKG: 1099) has announced a strategic partnership with Harbin...
NK Celltech and RongCan Biotech Partner to Advance mRNA NK Cell Therapy and LNP Delivery System
Shanghai-based NK Celltech and RongCan Biotech have entered into a partnership agreement to establish a...
Abbisko Therapeutics Initiates Phase II Clinical Trial for Pimicotinib in Tendon Sheath Giant Cell Tumor
Shanghai-based biotech Abbisko Therapeutics Co., Ltd (HKG: 2256) has announced the dosing of the first...
CASI Pharmaceuticals Enters Assignment Agreement with Mundipharma for Folotyn Commercialization in China
US-based CASI Pharmaceuticals Inc., (NASDAQ: CASI) has announced the execution of an assignment agreement with...
Astellas Pharma’s Zolbetuximab BLA Accepted by China’s CDE for Gastric Cancer Treatment
Japan-based Astellas Pharma Inc. (TYO: 4503) has announced that the Center for Drug Evaluation (CDE)...
Shanghai Junshi Biosciences Partners with Zein Biotechnology for PCSK9 mAb Commercialization in China
China-based Shanghai Junshi Biosciences Co., Ltd (HKG: 1877; SHA: 688180) has announced a partnership with...